Asked by: Marsha De Cordova (Labour - Battersea)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the potential merits of providing full funding for specialist palliative (a) care, (b) advice and (c) assessment provided by hospices.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
Integrated care boards (ICBs) are responsible for the commissioning of palliative care and end of life care services, to meet the needs of their local populations. To support ICBs in this duty, NHS England has published statutory guidance and service specifications. NHS England has also developed a palliative care and end of life care dashboard, which brings together all relevant local data in one place. The dashboard helps commissioners understand the palliative care and end of life care needs of their local population.
Whilst the majority of palliative care and end of life care is provided by National Health Service staff and services, we recognise the vital part that voluntary sector organisations, including hospices, also play in providing support to people at the end of life and their loved ones.
Most hospices are charitable, independent organisations which receive some statutory funding for providing NHS services. The amount of funding each charitable hospice receives varies both within and between ICB areas. This will vary depending on demand in that ICB area but will also be dependent on the totality and type of palliative and end of life care provision from both NHS and non-NHS services, including charitable hospices, within each ICB area.
The Department and NHS England are currently looking at how to improve the access, quality, and sustainability of all-age palliative care and end of life care in line with the 10- Year Health Plan. We will closely monitor the shift towards the strategic commissioning of palliative care and end of life care services to ensure that services reduce variation in access and quality, although some variation may be appropriate to reflect both innovation and the needs of local populations.
Additionally, we are supporting the hospice sector with a £100 million capital funding boost for eligible adult and children’s hospices in England to ensure they have the best physical environment for care.
We are also providing £26 million in revenue funding to support children and young people’s hospices for 2025/26. I am pleased to confirm the continuation of this vital funding for the next three financial years, from 2026/27 to 2028/29 inclusive. This funding will see approximately £26 million, adjusted for inflation, allocated to children and young people’s hospices in England each year, via their local ICBs on behalf of NHS England, as happened in 2024/25 and 2025/26. This amounts to approximately £80 million over the next three years.
Asked by: Marsha De Cordova (Labour - Battersea)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to help ensure that hospice contracts reflect the cost of (a) the services they provide and (b) the needs of their local populations.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
Integrated care boards (ICBs) are responsible for the commissioning of palliative care and end of life care services, to meet the needs of their local populations. To support ICBs in this duty, NHS England has published statutory guidance and service specifications. NHS England has also developed a palliative care and end of life care dashboard, which brings together all relevant local data in one place. The dashboard helps commissioners understand the palliative care and end of life care needs of their local population.
Whilst the majority of palliative care and end of life care is provided by National Health Service staff and services, we recognise the vital part that voluntary sector organisations, including hospices, also play in providing support to people at the end of life and their loved ones.
Most hospices are charitable, independent organisations which receive some statutory funding for providing NHS services. The amount of funding each charitable hospice receives varies both within and between ICB areas. This will vary depending on demand in that ICB area but will also be dependent on the totality and type of palliative and end of life care provision from both NHS and non-NHS services, including charitable hospices, within each ICB area.
The Department and NHS England are currently looking at how to improve the access, quality, and sustainability of all-age palliative care and end of life care in line with the 10- Year Health Plan. We will closely monitor the shift towards the strategic commissioning of palliative care and end of life care services to ensure that services reduce variation in access and quality, although some variation may be appropriate to reflect both innovation and the needs of local populations.
Additionally, we are supporting the hospice sector with a £100 million capital funding boost for eligible adult and children’s hospices in England to ensure they have the best physical environment for care.
We are also providing £26 million in revenue funding to support children and young people’s hospices for 2025/26. I am pleased to confirm the continuation of this vital funding for the next three financial years, from 2026/27 to 2028/29 inclusive. This funding will see approximately £26 million, adjusted for inflation, allocated to children and young people’s hospices in England each year, via their local ICBs on behalf of NHS England, as happened in 2024/25 and 2025/26. This amounts to approximately £80 million over the next three years.
Asked by: Marsha De Cordova (Labour - Battersea)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to help ensure the equitable provision of palliative care.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
Palliative care services are included in the list of services an integrated care board (ICB) must commission. To support ICBs in this duty, NHS England has published statutory guidance and service specifications. The statutory guidance states that ICBs must work to ensure that there is sufficient provision of care services to meet the needs of their local populations
NHS England has also developed a palliative care and end of life care dashboard, which brings together all relevant local data in one place. The dashboard helps commissioners understand the palliative care and end of life care needs of their local population, enabling ICBs to put plans in place to address and track the improvement of health inequalities, and ensure that funding is distributed fairly, based on prevalence.
The Department and NHS England are currently looking at how to improve the access, quality, and sustainability of all-age palliative care and end of life care in line with the 10-Year Health Plan.
We will closely monitor the shift towards the strategic commissioning of palliative care and end of life care services to ensure that services reduce variation in access and quality, although some variation may be appropriate to reflect both innovation and the needs of local populations.
Additionally, through the National Institute for Health and Care Research, the Department is investing £3 million in a Policy Research Unit in Palliative and End of Life Care. This unit, launched in January 2024, is building the evidence base on palliative care and end of life care, with a specific focus on inequalities.
Whilst the majority of palliative care and end of life care is provided by National Health Service staff and services, we recognise the vital part charitable hospices play as well. This is why we are supporting the hospice sector with a £100 million capital funding boost for eligible adult and children’s hospices in England to ensure they have the best physical environment for care.
We are also providing £26 million in revenue funding to support children and young people’s hospices for 2025/26. I am pleased to confirm the continuation of this vital funding for the next three financial years, from 2026/27 to 2028/29 inclusive. This funding will see approximately £26 million, adjusted for inflation, allocated to children and young people’s hospices in England each year, via their local ICBs on behalf of NHS England, as happened in 2024/25 and 2025/26. This amounts to approximately £80 million over the next three years.
Asked by: Marsha De Cordova (Labour - Battersea)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to provide adequate funding to hospices to increase staff pay in line with agreed NHS pay rises.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
We are immensely grateful for the critical role that healthcare workers, including hospice staff, play in our health service, and the high-quality, compassionate care they deliver.
The impact that National Health Service pay uplifts will have on the hospice sector will depend on the structure of the charity, including the number of employees and salary levels.
Independent organisations, such as charities and social enterprises, are free to develop and adapt their own terms and conditions of employment, including the pay scales. It is for them to determine what is affordable within the financial model they operate, and how to recoup any additional costs they face if they choose to utilise the terms and conditions of NHS staff on the Agenda for Change contract.
NHS England has issued guidance on the implementation of the 2024/25 pay awards. Providers of NHS-commissioned services should direct questions to their commissioners, either the local integrated care board (ICB) or NHS England regional team, on the application of their specific contract arrangements.
Additionally, we are supporting the hospice sector with a £100 million capital funding boost for eligible adult and children’s hospices in England to ensure they have the best physical environment for care.
We are also providing £26 million in revenue funding to support children and young people’s hospices for 2025/26. I am pleased to confirm the continuation of this vital funding for the next three financial years, from 2026/27 to 2028/29 inclusive. This funding will see approximately £26 million, adjusted for inflation, allocated to children and young people’s hospices in England each year, via their local ICBs on behalf of NHS England, as happened in 2024/25 and 2025/26. This amounts to approximately £80 million over the next three years.
Asked by: Marsha De Cordova (Labour - Battersea)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if the autologous serum eyedrop service will continue following the abolition of NHS England.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
NHS Blood and Transplant (NHSBT) is a Special Health Authority, and is responsible for blood donation in England and organ transplantation services in the United Kingdom. It is also responsible for stem cell transplants, tissue, and eye services.
Autologous serum eyedrops (ASE) are manufactured by NHSBT and are supplied to patients who experience severe dryness of the eye and who do not obtain relief from conventional pharmaceutical eyedrops. As such, ASE is supplied to patients following a clinical request from a consultant.
The Government does not anticipate the changes to NHS England will have any impacton the service NHSBT provides regarding ASE.
Asked by: Marsha De Cordova (Labour - Battersea)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of medical equipment shortages on (a) hospital discharges and (b) patients in community care settings.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
At the 2024 Autumn Budget, the Government announced a £22.6 billion increase in day-to-day health spending and a £3.1 billion increase in the capital budget over the financial years 2024/2025 and 2025/2026. Departmental budgets beyond 2025/26 will be set through phase two of the Spending Review, which will conclude and be published in June 2025.
Local authorities and National Health Service procuring authorities are responsible for discussing and agreeing contracts with community equipment suppliers, which will take into account the resources available to them. Timely provision of community equipment supports people to remain as independent as possible for as long as possible, and contributes significantly to the priorities of the Department, the NHS, and local authorities in terms of hospital avoidance and discharge.
Asked by: Marsha De Cordova (Labour - Battersea)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps the cross-government Health Mission Board plans to take to help tackle the impact of poverty on the health of disabled people.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
We have established a Health Mission Board to oversee and drive the delivery of the Health Mission. Mission Boards are Cabinet Committees. It is a long-established precedent that information about the proceedings of the Cabinet or of any committee of the Cabinet is not normally shared publicly; this includes mission boards.
One of the key goals of the Health Mission is a fairer Britain, where everyone lives well for longer. This includes championing the rights of disabled people. Under the Equality Act 2010, health and social care organisations must make reasonable adjustments to ensure that disabled people are not disadvantaged.
Asked by: Marsha De Cordova (Labour - Battersea)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 18 March 2025 to Question 32209 on Health and Care Act 2022, when he expects the Accessible Information Standard to (a) be published and (b) become mandatory.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
NHS England is working to support implementation of the Accessible Information Standard (AIS) with awareness raising, communication and engagement, and a review of the current e-learning modules on the AIS. The intention is to ensure that staff and organisations in the National Health Service are aware of the AIS and the importance of meeting the information and communication needs of disabled people using these services. The revised standards are expected to be published in summer 2025. In the meantime, the current AIS remains in force and public health and adult social care providers will continue to have due regard for it.
As part of new arrangements that will make information standards mandatory, following the commencement of regulations made under the Health and Care Act 2022, we intend to introduce mandatory information standards in a staged process. The Department and NHS England are considering what will be the first standards to be adopted under this process.
To ensure a frictionless transition from the existing information standards system to the new process for mandatory information standards, information standards made under the existing system will continue to have effect until they have been revoked, have expired, or have met the new procedural requirements and therefore become mandatory.
Asked by: Marsha De Cordova (Labour - Battersea)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential merits of providing support to the Medicines and Healthcare products Regulatory Agency in reviewing (a) guidance and (b) regulations for the (i) licensing and (ii) packaging of medicines to ensure their safe use by blind and partially sighted people.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The Medicines and Healthcare products Regulatory Agency (MHRA) already has provision in the current Human Medicines Regulations 2012 No 1916 legislation, to ensure the licensing and packaging of medicines are safe for use by blind and partially sighted people. These require manufacturers of medicines to include braille on their packaging of medicinal products, so that those who are partially sighted or who are blind can effectively identify the product they have been prescribed and dispensed.
They also require medicine manufacturers to provide an alternative version of the patient information leaflet (PIL), should the paper version contained in the box not be suitable in meeting the patients’ needs. These alternative versions may include braille or audio versions of the PIL. The MHRA’s best practice guidance also provides manufacturers with guidance on how to ensure they meet the requirements of the legislation.
The MHRA recognises that there is opportunity to improve patient information based upon user research, to ensure it fulfils the needs of this patient group and others. They are also committed to embedding patient voices across the regulatory pathways as part of their Patient Involvement Strategy 2021. The current strategy is also being refreshed for 2026 re-launch.
Asked by: Marsha De Cordova (Labour - Battersea)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if his Department will consult with blind and partially sighted patients on potential accessibility improvements to the NHS App.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
We are working to improve access to digital services, outcomes, and experiences for the widest range of people, based on their preferences. Patients unable to use digital channels can continue to access services via telephone and through traditional face to face services.
We conduct user research on an ongoing basis with users from diverse backgrounds to ensure our service works for everyone. This includes patients with a range of access needs and diverse groups, for instance ethnic minority groups, those with visual impairments, neurodiversity, and physical impairments. We have recruited users who are blind or partially sighted in community-based research, research with local National Health Service teams, and in remote research, either one to one or in groups. We use the findings of user research to plan and prioritise new work to improve accessibility.
Centrally built services, such as the NHS App and NHS website, are designed to meet international accessibility standards. We are modernising the mobile patient experience within the NHS App, ensuring information is clearly structured and easy to find and understand.